Letters to the Editor

SMAD1 promoter hypermethylation and lack of SMAD1 expression in Hodgkin lymphoma: a potential target for hypomethylating drug therapy

Institute of Medical Genetics and Pathology, University of Basel, Basel, Switzerland;
Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland;
Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland;
Institute of Pathology, Department of Pathology, Goethe University Frankfurt on Main, Germany
Institute of Pathology, Department of Pathology, Goethe University Frankfurt on Main, Germany
Institute of Medical Genetics and Pathology, University of Basel, Basel, Switzerland;
Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland;
Institute of Pathology, Department of Pathology, Goethe University Frankfurt on Main, Germany
Institute of Medical Genetics and Pathology, University of Basel, Basel, Switzerland;
Haematologica Early view Apr 16, 2020 https://doi.org/10.3324/haematol.2020.249276